<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Evid Based Complement Alternat Med</journal-id><journal-id journal-id-type="publisher-id">ecam</journal-id><journal-id journal-id-type="hwp">ecam</journal-id><journal-title>Evidence-based Complementary and Alternative Medicine : eCAM</journal-title><issn pub-type="ppub">1741-427X</issn><issn pub-type="epub">1741-4288</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">18955221</article-id><article-id pub-id-type="pmc">2644277</article-id><article-id pub-id-type="doi">10.1093/ecam/nem067</article-id><article-id pub-id-type="publisher-id">nem067</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Articles &#x02013; Basic Science</subject></subj-group></article-categories><title-group><article-title>Amelioration of Carcinogen-Induced Toxicity in Mice by Administration of a Potentized Homeopathic Drug, Natrum Sulphuricum 200</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Bhattacharjee</surname><given-names>Nandini</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pathak</surname><given-names>Surajit</given-names></name></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Khuda-Bukhsh</surname><given-names>Anisur Rahman</given-names></name></contrib></contrib-group><aff>Cytogenetics and Molecular Biology Laboratory, Department of Zoology, University of Kalyani, Kalyani-741235, India</aff><author-notes><corresp>For reprints and all correspondence: Anisur Rahman Khuda-Bukhsh, Department of Zoology, University of Kalyani, Kalyani-741235, India. Tel: <phone>+91-33-25828750</phone> extn. 315; Fax: <fax>+91-33-25828282</fax>; E-mail: <email>prof_arkb@yahoo.co.in</email>; <email>khudabukhsh_48@rediffmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><month>3</month><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>6</month><year>2007</year></pub-date><volume>6</volume><issue>1</issue><fpage>65</fpage><lpage>75</lpage><history><date date-type="received"><day>27</day><month>11</month><year>2006</year></date><date date-type="accepted"><day>8</day><month>5</month><year>2007</year></date></history><permissions><copyright-statement>&#x000a9; 2007 The Author(s).</copyright-statement><copyright-year>2007</copyright-year><license license-type="creative-commons" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/"><p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/2.0/uk/">http://creativecommons.org/licenses/by-nc/2.0/uk/</ext-link>) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><p>To examine if a potentized homeopathic drug, Natrum Sulphuricum 200 (Nat Sulph-200) has protective potentials against hepatocarcinogenesis, liver tumors were induced in mice through chronic feeding of <italic>P</italic>-dimethylaminoazobenzene (p-DAB; initiator of hepatocarcinogenesis) and phenobarbital (PB; promoter). Mice were divided into five sub-groups: fed normal low protein diet (Gr. I, normal control); fed normal low protein plus alcohol-200 (vehicle of the homeopathic remedy) (Gr. II); fed diet mixed with 0.06% p-DAB plus 0.05% PB (Gr. III); fed diet and carcinogens like Gr.III, plus alcohol 200 (positive control for drug fed mice) (Gr. IV) and fed diet and carcinogens like Gr. III, plus Natrum Sulphuiricum-200 (Gr. V; drug fed). Mice were sacrificed at day 7, 15, 30, 60, 90 and day 120 for study of cytogenetical endpoints like chromosome aberrations (CA), micronuclei (MN), mitotic index (MI) and sperm head anomaly (SHA) and biochemical toxicity parameters like aspartate amino transferase (AST), alanine amino transferase (ALT), acid (AcP) and alkaline (AlkP) phosphatases, lipid peroxidation (LPO) and reduced glutathione (GSH) content. Less number of liver tumors were observed in Gr. V (drug fed) mice. Administration of Nat Sulph 200 reduced genomic damage, activities of AcP, AlkP, AST, ALT, LPO and increased GSH content. Therefore, independent replication of the study by others is encouraged.</p></abstract><kwd-group><kwd>anti-carcinogenesis</kwd><kwd>azo dye induced liver cancer</kwd><kwd>geno- and cyto-toxicity biomarkers homeopathic remedy</kwd><kwd>mice</kwd></kwd-group></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Complementary and alternative medicine (CAM) is one of the growing areas in health care today (<xref ref-type="bibr" rid="B1 B2 B3 B4">1&#x02013;4</xref>), particularly as supportive medicine in treating difficult to cure diseases like cancer (<xref ref-type="bibr" rid="B5 B6 B7">5&#x02013;7</xref>). Homeopathy is becoming one of the popular alternative modes of treatment (<xref ref-type="bibr" rid="B8 B9 B10">8&#x02013;10</xref>). Because of ultra high dilutions of most potentized homeopathic drugs, their efficacy in treating diseases is often put to question. However, our recent works which showed the efficacy of certain homeopathic drugs in ameliorating p-dimethylaminoazobenzene (p-DAB) induced cancer in mice (<xref ref-type="bibr" rid="B11 B12 B13 B14">11&#x02013;14</xref>) have aroused interest in testing other homeopathic drugs for their possible anti-cancer effects. The azo dye p-DAB, used occasionally as a food additive, is known to act as initiator of liver cancer when used chronically (<xref ref-type="bibr" rid="B15 B16 B17 B18 B19">15&#x02013;19</xref>) and is known to cause hazard to humans and animals (<xref ref-type="bibr" rid="B20 B21">20&#x02013;21</xref>). Phenobarbital (PB), predominantly used as an anti-epileptic/sedative drug, is known to have carcinogenic effect (<xref ref-type="bibr" rid="B22">22</xref>) to humans, mice and rats when administrated repeatedly (<xref ref-type="bibr" rid="B23 B24 B25 B26">23&#x02013;26</xref>). The effects are more pronounced when PB is used in combination with the azo-dye, which unfailingly produce liver tumors that ultimately become neoplastic (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B27">27</xref>). Therefore this induced liver carcinoma serves as a good model for the study of events during carcinogenesis as well as to test if a drug has any anti-cancerous effect. Further, homeopathic mode of treatment does not have any known side effects and is less expensive than that of conventional treatments of liver cancer which often needs surgery and costly medicines in management.</p><sec><title>Remedy Selection: Indication from a Pilot Study</title><p>We have for some time been screening some homeopathic remedies, which are claimed to have pronounced effects in protecting liver from toxicity or that are known to help in recovery of liver dysfunction (e.g. Chelidonium, Lycopodium, etc.), for their possible anti-hepatotoxic/anti-tumorigenic effects since the primary target organ of the carcinogens is the liver.</p><p>Potentized form of Natrum Sulphuricum is one such remedy generally used by homeopathic practitioners for various liver disorders having agreeable symptoms (<xref ref-type="bibr" rid="B28">28</xref>). As chronic feeding of <italic>P-DAB</italic> and PB is known to cause symptoms arising out of liver disorders and Natrum Sulph being one of the remedies used to alleviate and protect liver from toxic effects, we first conducted a pilot study on the efficacy of Nat Sulph-30 with a limited number of protocols (data unpublished). On getting a positive result the present investigation was undertaken with a primary objective of evaluating efficacy of Nat Sulph-200 (a more diluted higher potency claimed to have stronger and longer lasting effect) in amelioration of carcinogen induced toxicity in mice utilizing several widely accepted protocols of cytogenetical and biochemical studies.</p></sec><sec><title>Implications In Brief of the Parameters Used</title><p>The parameters used in this study are important genotoxicity and cyto-toxicity (particularly hepatotoxin) biomarkers, either directly or indirectly implicated in the development of liver tumors. The changes observed in the cytogenetical studies led to the studies of LPO, which is associated with tissue damage and necrosis. Similarly, tissue damage and necrosis can lead to improper liver function and thereby causing hepato-toxicity. For this, liver function tests, that include the assay of various enzymes like AcP, AlkP, AST and ALT were selected to throw light on the extent of liver malfunctioning, if any. Further, if hepato-toxicity is generated, there will be generation of free radicals. GSH has anti-oxidant activity which is accomplished by scavenging free-radicals and the study of GSH was therefore of added value. Further, while decrease of the other biochemical parameters indicates decreased epato-toxicity, a concomitant increase in GSH is expected to confirm this.</p></sec></sec><sec sec-type="methods"><title>Methods</title><sec><title>Feeding the Carcinogens and the Homeopathic Remedy to Mice</title><p>An inbred strain of Swiss albino mice (<italic>Mus musculus</italic>) were reared and maintained in the animal house of the Department of Zoology (with clearance from the University Ethical Committee and under the supervision of the Animal Welfare Committee), University of Kalyani, India, for the investigation. Mice under experiment were provided food and water and kept in a hygienic condition. The general diet was prepared from wheat, gram and powdered milk without any animal protein supplement. A group of 36 healthy mice weighing between 25&#x02013;30 g were used for each treatment series, namely, (i) normal, (ii) normal + alcohol 200 (iii) <italic>P</italic>-dimethylaminoazobenzene (p-DAB) + phenobarbital (PB), (iv) p-DAB + PB + alcohol 200, (v) p-<italic>DAB</italic> + PB + Nat Sulph-200 fed series. In our earlier studies, we used to maintain another group, only verum fed control along with normal + succussed alcohol fed control. But since the differences in data between these two series were negligible or insignificant, the normal + verum fed group as control was later abandoned for saving life of mice and cost.</p><p>Each group of 36 mice divided into six different sets consisting of six mice each for six different intervals of fixation, namely, at day seven, 15, 30, 60, 90 and 120. The first set of mice (group-I, normal, negative control) was fed normal low protein diet. The second set of mice (group II) was fed diluted alcohol 200 (potentized as per homeopathic principle of dilution and succussion) with normal low protein diet. The third set of mice (group-III) was fed the same diet but mixed with 0.06% p-DAB (Sigma, D-6760) at a daily dose of 165 mg/kg body wt. per mouse (<xref ref-type="bibr" rid="B15">15</xref>,<xref ref-type="bibr" rid="B27">27</xref>,<xref ref-type="bibr" rid="B29">29</xref>) and an oral dose of 0.06 ml of 0.05% aqueous solution of PB daily (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B30">30</xref>) through a specially made fine pipette. The fourth set of mice (group-IV, positive control) was fed 0.06% p-DAB along with 0.05% aqueous solution of PB as above and also diluted alcohol 200 (alc-200: as the &#x02018;vehicle&#x02019; of the drug was ethyl alcohol), till they were sacrificed. The fifth set of mice (group-V) was fed p-DAB plus PB as in group-III, but was also fed Nat Sulph-200 once a day till they were sacrificed at day seven, 15, 30, 60, 90 and 120.</p></sec><sec><title>Feeding Procedure and Dose</title><p>Each mouse was fed one drop (0.06 ml) of stock solution of Nat Sulph-200 or alc-200, as the case may be, once daily (one dose at 7 A.M) with the aid of a fine pipette.</p></sec><sec><title>Preparation of the Potentized Form of the Drug</title><p>The potentized homeopathic drug, Nat Sulph-200, was procured from &#x02018;HAPCO&#x02019;, 165, Bipin Behari Ganguly Street, Kolkata, India. The 200 potency of Natrum Sulph was derived from the mother tincture of sodium sulphate by &#x02018;succussion and dilution&#x02019; procedure (<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>) as recommended in the Homeopathic Pharmacopoeia of India, Vol. I (<xref ref-type="bibr" rid="B33">33</xref>). The glass vial containing potentized alc-200 provided by &#x02018;HAPCO&#x02019; having been accidentally broken during the initial days of experiment, the available &#x02018;placebo&#x02019; provided by Boiron Lab, Lyon, France, had been used. However, we examined various physical properties of both the &#x02018;placebos&#x02019; prepared by &#x02018;HAPCO&#x02019; and &#x02018;BOIRON&#x02019; through UV, FTIR, fluorescence, 13 C-NMR and 1H-NMR spectroscopy earlier (<xref ref-type="bibr" rid="B34">34</xref>) but failed to observe any significant difference between the two &#x02018;placebos&#x02019;.</p></sec><sec><title>Laboratory Methodology</title><sec><title>Cytogenetic Assay</title><p>The standard and widely practiced cytogenetic protocols like assays of chromosome aberration (CA), micronuclei (MN), mitotic index (MI) and sperm head anomaly (SHA) have been adopted in the present study for testing genotoxicity (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B26">26</xref>). A total of 300 bone marrow cells were observed for CA, 3000 cells for MN and 5000 cells for MI and 5000 sperm for SHA analysis. </p></sec><sec><title>Biochemical Assays</title><p>After collection of blood by ventricular puncture from etherized mice (approx 1.5 ml from each mouse), they were sacrificed and their liver and spleen were quickly collected in an ice tray.</p><p>For the study of aspartate and alanine amino transferases (AST and ALT, respectively), acid and alkaline phosphatases (AcP and AlkP, respectively) and lipid peroxidation (LPO) and reduced glutathione content (GSH) standard methods (<xref ref-type="bibr" rid="B14">14</xref>) were adopted.</p></sec></sec><sec><title>Statistical Analysis</title><p>The significance of difference between data of the different series was conducted by Student's <italic>t</italic>-test and two-way ANOVA (Mini Tab 13.01) was performed. This experiment was done as per randomized double blind placebo control method.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Tumor Growth</title><p>Out of 18 mice sacrificed at three longer fixation intervals (i.e. at day 60, 90 and 120), 15 and 16 mice, respectively, showed liver tumors in the p-DAB + PB fed and p-<italic>DAB</italic> + PB + alc-200 fed series, while altogether eight mice showed liver tumors in the drug fed series (<xref ref-type="table" rid="T1">Table 1</xref>). The tumors looked pale reddish in color. Some of them were present as solitary or a few individually distinguishable ones (mostly in drug fed mice) much less in magnitude than the multiple innumerable nodules (mostly in drug unfed mice), which were considered as true tumors and the one or two nodules present in a few were ignored. On this estimate, Nat Sulph-200 fed mice showed an overall protection to the tune of 41.7% (Nat Sulph-30 rendered 31.1%, unpublished data) when data of all three longer intervals of fixation were considered.<table-wrap id="T1" position="float"><label>Table 1.</label><caption><p>Number of animals showing tumors at different fixation intervals after chronic feeding of p-DAB plus PB for 7, 15, 30, 60, 90 and 120 days, in each fixation intervals 6 mice each were used per set</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Series</th><th rowspan="1" colspan="1">No. of specimens used</th><th rowspan="1" colspan="1">Tumor incidence 7 days</th><th rowspan="1" colspan="1">Tumor incidence 15 days</th><th rowspan="1" colspan="1">Tumor incidence 30 days</th><th rowspan="1" colspan="1">Tumor incidence 60 days</th><th rowspan="1" colspan="1">Tumor incidence 90 days</th><th rowspan="1" colspan="1">Tumor incidence 120 days</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td></tr><tr><td rowspan="1" colspan="1">Normal + Alc-200</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">3/6</td><td rowspan="1" colspan="1">6/6</td><td rowspan="1" colspan="1">6/6</td></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alc-200</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">4/6</td><td rowspan="1" colspan="1">6/6</td><td rowspan="1" colspan="1">6/6</td></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat Sulph-200</td><td rowspan="1" colspan="1">36</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">0/6</td><td rowspan="1" colspan="1">2/6</td><td rowspan="1" colspan="1">3/6</td><td rowspan="1" colspan="1">3/6</td></tr><tr><td rowspan="1" colspan="1">TOTAL</td><td rowspan="1" colspan="1">180</td><td rowspan="1" colspan="1">0/30</td><td rowspan="1" colspan="1">0/30</td><td rowspan="1" colspan="1">0/30</td><td rowspan="1" colspan="1">9/30</td><td rowspan="1" colspan="1">15/30</td><td rowspan="1" colspan="1">15/30</td></tr></tbody></table></table-wrap></p></sec><sec><title>Cytogenetical Studies</title><p>As compared with normal metaphase plate (<xref ref-type="fig" rid="F1">Fig.1A</xref>), there was a palpable increase in the frequencies of various types of CA (<xref ref-type="fig" rid="F1">Fig. 1</xref>B&#x02013;D) in different treatment series during all fixation periods. Several types of chromosome aberrations &#x02014; both of major and minor types &#x02014; were observed in certain metaphase plates of p-<italic>DAB</italic> + PB and p-DAB + PB + alc-200 fed mice. The total frequencies of aberrations were maximum in p-<italic>DAB</italic> + PB + alc-200 fed mice. The frequency of CA was always greater in p-DAB + PB fed mice than in normal (Gr. I) and normal + alc-200 fed (Gr. II) mice. The frequency of CA in p-DAB + PB + Nat Sulph-200 fed group was found to be considerably decreased (<italic>P</italic> &#x0003c; 0.01&#x02013;<italic>P</italic> &#x0003c; 0.001) at all fixation intervals except at day seven (<xref ref-type="fig" rid="F2">Fig. 2</xref>A).<fig id="F1" position="float"><label>Figure 1.</label><caption><p>(A&#x02013;F). (<bold>A</bold>) Photomicrographs of normal metaphase complement, (<bold>B</bold>): Ring (R) and Centric fusion (CF), (<bold>C</bold>): Polyploidy, (<bold>D</bold>): Terminal association (TA), (<bold>E</bold>): Erythrocyte showing micronucleus; (<bold>F</bold>): Sperm with abnormal head shape.</p></caption><graphic xlink:href="nem067f1"/></fig><fig id="F2" position="float"><label>Figure 2.</label><caption><p>(A&#x02013;D). Histograms showing the following: (<bold>A</bold>) percentage (%) of chromosomal aberrations (CA) in different series of mice at different fixation intervals; (<bold>B</bold>) percentage (%) of micronucleated erythrocytes (MN) in different series of mice at different fixation intervals; (<bold>C</bold>) percentage (%) of mitotic indices in different series of mice at different fixation intervals; and (<bold>D</bold>) percentage (%) of sperm head anomalies (SHA) in different series of mice at different fixation intervals. Statistical analyses were done between series p-DAB + PB + Alcohol-200 versus p-DAB + PB + Nat Sulph-200. The different levels of statistical significances between two given series have been designated by *<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001. p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200.</p></caption><graphic xlink:href="nem067f2"/></fig></p></sec><sec><title>Micronucleated Erythrocytes</title><p>The incidence of micronuclei (<xref ref-type="fig" rid="F1">Fig. 1</xref>E; which represent a fragment or broken part or whole arm of a chromosome), in carcinogen fed as also p-DAB + PB + alc-200 fed mice was appreciably higher than that of normal control mice at all fixation intervals. However, there was a palpable decrease in MN in the drug fed series (<italic>P</italic> &#x0003c; 0.05&#x02013;<italic>P</italic> &#x0003c; 0.001). The decrease was a result of reduction in number of both polychromatic (PCE) and normochromatic (NCE) erythrocytes (<xref ref-type="fig" rid="F2">Fig. 2</xref>B).</p></sec><sec><title>Mitotic Index</title><p>The mitotic indices represent the rate at which the cells pass through a cell cycle. When a cell becomes transformed into a tumor cell, the rate becomes increased for failure of proper control of cell division and thus may be used as an indicator of tumorigenicity. The mitotic indices of mice fed either p-DAB + PB or p-DAB + PB + Alc-200 were higher than that of the normal control series. In p-DAB + PB + Nat Sulph-200 fed mice, there was a significant decrease (<italic>P</italic> &#x0003c; 0.05&#x02013;<italic>P</italic> &#x0003c; 0.001) in MI at all fixation intervals except at day seven (<xref ref-type="fig" rid="F2">Fig. 2</xref>C).</p></sec><sec><title>Sperm Head Anomaly</title><p>Genotoxic or carcinogenic or spermatotoxic agents can cause damage to sperm head, which may be an indicator of the risk of transmission of mutagenic trait, if these deformed sperm by chance fertilize the ovum. Greater number of sperm with abnormal head morphologies (<xref ref-type="fig" rid="F1">Fig. 1</xref>G) was encountered in p-DAB + PB fed and p-<italic>DAB</italic> + PB + alc-200 fed mice at all fixation intervals. The frequencies of SHA were considerably decreased in p-DAB + PB + Nat Sulph-200 fed group at all fixation intervals (<italic>P</italic> &#x0003c; 0.05&#x02013;<italic>P</italic> &#x0003c; 0.001) (<xref ref-type="fig" rid="F2">Fig. 2</xref>D) except at day 7.</p></sec><sec><title>Biochemical Assay</title><sec><title>Aspartate Amino Transferase Activity (AST)</title><p>The AST activity in liver was increased in both p-<italic>DAB</italic> + PB fed and p-DAB + PB + Alc-200 fed mice at all fixation intervals. However, the AST activity in p-<italic>DAB</italic> + PB + Nat Sulph-200 fed series appeared to decrease significantly (<italic>P</italic> &#x0003c; 0.01&#x02013;<italic>P</italic> &#x0003c; 0.001) from day 15 &#x02013; day 120 (<xref ref-type="table" rid="T2">Table 2</xref>) in liver.<table-wrap id="T2" position="float"><label>Table 2.</label><caption><p>Mean Aspartate amino transferase (AST) activity in (nM/ 100 mg protein/ Min) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF1">*</xref>, <xref ref-type="table-fn" rid="TF1">**</xref>, <xref ref-type="table-fn" rid="TF1">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><td rowspan="1" colspan="1">Series</td><td colspan="2" rowspan="1">AST activity &#x000b1; SE<hr/></td><td colspan="2" rowspan="1">AST activity &#x000b1; SE<hr/></td><td colspan="2" rowspan="1">AST activity &#x000b1; SE<hr/></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.017 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.012 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.021 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.026 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.011 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.020 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.040 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.041 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.049 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.043 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.045 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.054 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.050 &#x000b1; 0.003</td><td rowspan="1" colspan="1">&#x02212;0.007<sup><italic>n</italic></sup></td><td rowspan="1" colspan="1">0.040&#x000b1;0.001</td><td rowspan="1" colspan="1">0.005<xref ref-type="table-fn" rid="TF1">**</xref></td><td rowspan="1" colspan="1">0.036 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.018<xref ref-type="table-fn" rid="TF1">***</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">60 days</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">90 days</th><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">120 days</th><th rowspan="1" colspan="1"/></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">AST activity &#x000b1; SE</th><th colspan="2" rowspan="1">AST activity &#x000b1; SE</th><th colspan="2" rowspan="1">AST activity &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.024 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.010 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.054 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.021 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.012 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.056 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.047 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.056 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.075 &#x000b1; 0.007</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.053 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.059 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.107 &#x000b1; 0.012</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.032 &#x000b1; 0.004</td><td rowspan="1" colspan="1">0.021<xref ref-type="table-fn" rid="TF1">**</xref></td><td rowspan="1" colspan="1">0.041 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.018<xref ref-type="table-fn" rid="TF1">***</xref></td><td rowspan="1" colspan="1">0.046 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.061<xref ref-type="table-fn" rid="TF1">***</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF1"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01,***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Alanine Amino Transferase Activity (ALT)</title><p>Similar trend of reduction in ALT activity (<italic>P</italic> &#x0003c; 0.01&#x02013;<italic>P</italic> &#x0003c; 0.001) was noticed in liver of the p-Dab + PB + Nat Sulph-200 fed mice when compared to that of p-Dab + PB + Alc-200 fed mice at all fixation intervals except at day seven (<xref ref-type="table" rid="T3">Table 3</xref>).<table-wrap id="T3" position="float"><label>Table 3.</label><caption><p>Mean Alanine amino transferase (ALT) activity in (nM/ 100 mg protein/ Min) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF2">*</xref>, <xref ref-type="table-fn" rid="TF2">**</xref>, <xref ref-type="table-fn" rid="TF2">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><td rowspan="1" colspan="1">Series</td><td colspan="2" rowspan="1">ALT activity &#x000b1; SE<hr/></td><td colspan="2" rowspan="1">ALT activity &#x000b1; SE<hr/></td><td colspan="2" rowspan="1">ALT activity &#x000b1; SE<hr/></td></tr><tr><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td><td rowspan="1" colspan="1">Liver</td><td rowspan="1" colspan="1">Difference in activity</td></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.010 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.005 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.011 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.012 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.009 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.009 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.028 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.017 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.014 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.036 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.022 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.021 &#x000b1; 0.001</td><td rowspan="1" colspan="1">&#x02212;0.007<sup><italic>n</italic></sup></td><td rowspan="1" colspan="1">0.026 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.010<xref ref-type="table-fn" rid="TF2">**</xref></td><td rowspan="1" colspan="1">0.014 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.008<xref ref-type="table-fn" rid="TF2">**</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">60 days</th><th colspan="2" rowspan="1">90 days</th><th colspan="2" rowspan="1">120 days</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">ALT activity &#x000b1; SE</th><th colspan="2" rowspan="1">ALT activity &#x000b1; SE</th><th colspan="2" rowspan="1">ALT activity &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.004 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.007 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.005 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.015 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.015 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.019 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.024 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.017 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.020 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.011 &#x000b1; 0.003</td><td rowspan="1" colspan="1">0.013<xref ref-type="table-fn" rid="TF2">**</xref></td><td rowspan="1" colspan="1">0.004 &#x000b1; 0.000</td><td rowspan="1" colspan="1">0.013<xref ref-type="table-fn" rid="TF2">***</xref></td><td rowspan="1" colspan="1">0.011 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.009<xref ref-type="table-fn" rid="TF2">**</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF2"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Acid Phosphatase Activity (AcP)</title><p>The activity of AcP in liver showed a trend of steady rise from day 7 to day 15 in p-Dab + PB fed mice, then decreased at day 60 and 90, only to rise again at day 120. The same trend was noticed in the p-Dab + PB + Alc-200 fed series. The activity of AcP was decreased significantly (<italic>P</italic> &#x0003c; 0.01) (<xref ref-type="table" rid="T4">Table 4</xref>) in the drug fed mice at all fixation intervals except at day 7.<table-wrap id="T4" position="float"><label>Table 4.</label><caption><p>Mean Acid phosphatase (AcP) activity in (nM/ 100 mg protein/ Min) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF3">*</xref>, <xref ref-type="table-fn" rid="TF3">**</xref>, <xref ref-type="table-fn" rid="TF3">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><th rowspan="1" colspan="1">Series</th><th colspan="2" rowspan="1">AcP activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">AcP activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">AcP activity &#x000b1; SE<hr/></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.048 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.143 &#x000b1; 0.007</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.040 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.044 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.128 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.036 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.080 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.157 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.086 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.086 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.153 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.089 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.087 &#x000b1; 0.003</td><td rowspan="1" colspan="1">&#x02212;0.001<sup><italic>n</italic></sup></td><td rowspan="1" colspan="1">0.137 &#x000b1; 0.004</td><td rowspan="1" colspan="1">0.016<xref ref-type="table-fn" rid="TF3">**</xref></td><td rowspan="1" colspan="1">0.074 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.015<xref ref-type="table-fn" rid="TF3">**</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">60 days</th><th colspan="2" rowspan="1">90 days</th><th colspan="2" rowspan="1">120 days</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">AcP activity &#x000b1; SE</th><th colspan="2" rowspan="1">AcP activity &#x000b1; SE</th><th colspan="2" rowspan="1">AcP activity &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.046 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.012 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.025 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.045 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.021 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.032 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.076 &#x000b1; 0.009</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.053 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.128 &#x000b1; 0.013</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.083 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.055 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.131 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.052 &#x000b1; 0.006</td><td rowspan="1" colspan="1">0.031<xref ref-type="table-fn" rid="TF3">**</xref></td><td rowspan="1" colspan="1">0.043 &#x000b1; 0.003</td><td rowspan="1" colspan="1">0.012<xref ref-type="table-fn" rid="TF3">**</xref></td><td rowspan="1" colspan="1">0.087 &#x000b1; 0.003</td><td rowspan="1" colspan="1">0.044<xref ref-type="table-fn" rid="TF3">**</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF3"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Alkaline Phosphatase Activity (AlkP)</title><p>The activity of AlkP was enhanced in liver of p-Dab + PB fed mice from day seven through day 120 and the same in p-Dab + PB + Nat Sulph-200 fed mice decreased appreciably (<italic>P</italic> &#x0003c; 0.05 through <italic>P</italic> &#x0003c; 0.001) at all fixation intervals (<xref ref-type="table" rid="T5">Table 5</xref>).<table-wrap id="T5" position="float"><label>Table 5.</label><caption><p>Mean Alkaline phosphatase (AlkP) activity in (nM/ 100 mg protein/ Min) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF4">*</xref>, <xref ref-type="table-fn" rid="TF4">**</xref>, <xref ref-type="table-fn" rid="TF4">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><th rowspan="1" colspan="1">Series</th><th colspan="2" rowspan="1">AlkP activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">AlkP activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">AlkP activity &#x000b1; SE<hr/></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.017 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.014 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.024 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.026 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.016 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.027 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.038 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.026 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.044 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.044 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.030 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.050 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.049 &#x000b1; 0.008</td><td rowspan="1" colspan="1">&#x02212;0.005<sup><italic>n</italic></sup></td><td rowspan="1" colspan="1">0.022 &#x000b1; 0.003</td><td rowspan="1" colspan="1">0.008<xref ref-type="table-fn" rid="TF4">*</xref></td><td rowspan="1" colspan="1">0.036 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.014<xref ref-type="table-fn" rid="TF4">*</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">60 days</th><th colspan="2" rowspan="1">90 days</th><th colspan="2" rowspan="1">120 days</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">AlkP activity &#x000b1; SE</th><th colspan="2" rowspan="1">AlkP activity (activity &#x000b1; SE)</th><th colspan="2" rowspan="1">AlkP activity &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.021 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.019 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.012 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.023 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.026 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.033 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.034 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.045 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.139 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.038 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.048 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.150 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.028 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.010<xref ref-type="table-fn" rid="TF4">**</xref></td><td rowspan="1" colspan="1">0.032 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.016<xref ref-type="table-fn" rid="TF4">*</xref></td><td rowspan="1" colspan="1">0.115 &#x000b1; 0.004</td><td rowspan="1" colspan="1">0.035<xref ref-type="table-fn" rid="TF4">***</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF4"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Lipid Peroxidation (LPO)</title><p>Lipid peroxidation was considerably higher in p-Dab + PB + Alc-200 fed mice. However, there was a significant decrease (<italic>P</italic> &#x0003c; 0.05 through <italic>P</italic> &#x0003c; 0.001) in lipid peroxidation in liver of p-Dab + PB + Nat Sulph-200 fed mice at all fixation intervals (<xref ref-type="table" rid="T6">Table 6</xref>).<table-wrap id="T6" position="float"><label>Table 6.</label><caption><p>Mean Lipid peroxidation (LPO) activity in (nM/ MDA/ mg wet tissue) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF5">*</xref>, <xref ref-type="table-fn" rid="TF5">**</xref>, <xref ref-type="table-fn" rid="TF5">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><th rowspan="1" colspan="1">Series</th><th colspan="2" rowspan="1">LPO activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">LPO activity &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">LPO activity &#x000b1; SE<hr/></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.245 &#x000b1; 0.008</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.135 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.086 &#x000b1; 0.002</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.272 &#x000b1; 0.013</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.172 &#x000b1; 0.005</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.094 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.332 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.312 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.234 &#x000b1; 0.008</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.355 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.349 &#x000b1; 0.037</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.270 &#x000b1; 0.009</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.417 &#x000b1; 0.011</td><td rowspan="1" colspan="1">&#x02212;0.062<sup><italic>n</italic></sup></td><td rowspan="1" colspan="1">0.192 &#x000b1; 0.002</td><td rowspan="1" colspan="1">0.157<xref ref-type="table-fn" rid="TF5">**</xref></td><td rowspan="1" colspan="1">0.219 &#x000b1; 0.014</td><td rowspan="1" colspan="1">0.051<xref ref-type="table-fn" rid="TF5">*</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">60 days</th><th colspan="2" rowspan="1">90 days</th><th colspan="2" rowspan="1">120 days</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">LPO activity &#x000b1; SE</th><th colspan="2" rowspan="1">LPO activity &#x000b1; SE</th><th colspan="2" rowspan="1">LPO activity &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.052 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.043 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.048 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.054 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.070 &#x000b1; 0.008</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.074 &#x000b1; 0.004</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.247 &#x000b1; 0.012</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.119 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.131 &#x000b1; 0.009</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.254 &#x000b1; 0.010</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.124 &#x000b1; 0.003</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.149 &#x000b1; 0.006</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.141 &#x000b1; 0.009</td><td rowspan="1" colspan="1">0.113<xref ref-type="table-fn" rid="TF5">***</xref></td><td rowspan="1" colspan="1">0.090 &#x000b1; 0.004</td><td rowspan="1" colspan="1">0.034<xref ref-type="table-fn" rid="TF5">***</xref></td><td rowspan="1" colspan="1">0.118 &#x000b1; 0.004</td><td rowspan="1" colspan="1">0.03 1<xref ref-type="table-fn" rid="TF5">**</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF5"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec><sec><title>Reduced Glutathione Content (GSH)</title><p>The reduced glutathione content decreased in p-Dab + PB + Alc-200 fed mice at all fixation intervals. However, there was an increase in reduced glutathione content of p-Dab + PB + Nat Sulph-200 fed mice at all fixation intervals (<italic>P</italic> &#x0003c; 0.05 to <italic>P</italic> &#x0003c; 0.01) (<xref ref-type="table" rid="T7">Table 7</xref>) in liver.<table-wrap id="T7" position="float"><label>Table 7.</label><caption><p>Mean Reduced glutathione (GSH) content in (nM/ mg wet tissue) in liver of mice treated with p-DAB + PB, p-DAB + PB + alc-200, p-DAB + PB + Nat Sulph-200, normal and negative controls at different fixation intervals. The different levels of statistical significances between two given series have been designated by <xref ref-type="table-fn" rid="TF6">*</xref>, <xref ref-type="table-fn" rid="TF6">**</xref>, <xref ref-type="table-fn" rid="TF6">***</xref></p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Fixation intervals in days<hr/></th><th colspan="2" rowspan="1">7 days<hr/></th><th colspan="2" rowspan="1">15 days<hr/></th><th colspan="2" rowspan="1">30 days<hr/></th></tr><tr><th rowspan="1" colspan="1">Series</th><th colspan="2" rowspan="1">GSH content &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">GSH content &#x000b1; SE<hr/></th><th colspan="2" rowspan="1">GSH content &#x000b1; SE<hr/></th></tr><tr><th rowspan="1" colspan="1"/><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th><th rowspan="1" colspan="1">Liver</th><th rowspan="1" colspan="1">Difference in activity</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.004 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.005 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Al cohol</td><td rowspan="1" colspan="1">0.004 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.004 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1">0.000</td><td rowspan="1" colspan="1">0.003 &#x000b1; 0.000</td><td rowspan="1" colspan="1">0.002</td><td rowspan="1" colspan="1">0.004 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.003<xref ref-type="table-fn" rid="TF6">*</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">60 days</th><th colspan="2" rowspan="1">90 days</th><th colspan="2" rowspan="1">120 days</th></tr><tr><th rowspan="1" colspan="1"/><th colspan="2" rowspan="1">GSH content &#x000b1; SE</th><th colspan="2" rowspan="1">GSH content &#x000b1; SE</th><th colspan="2" rowspan="1">GSH content &#x000b1; SE</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Normal</td><td rowspan="1" colspan="1">0.005 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.007 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">Normal + Alcohol</td><td rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.005 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB</td><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.002 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.003 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Alcohol</td><td rowspan="1" colspan="1">0.001 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.003 &#x000b1; 0.000</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1">0.003 &#x000b1; 0.001</td><td rowspan="1" colspan="1"/></tr><tr><td rowspan="1" colspan="1">p-DAB + PB + Nat</td><td rowspan="1" colspan="1">0.005 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.004<xref ref-type="table-fn" rid="TF6">**</xref></td><td rowspan="1" colspan="1">0.006 &#x000b1; 0.001</td><td rowspan="1" colspan="1">0.003<xref ref-type="table-fn" rid="TF6">*</xref></td><td rowspan="1" colspan="1">0.006 &#x000b1; 0.000</td><td rowspan="1" colspan="1">0.003<xref ref-type="table-fn" rid="TF6">*</xref></td></tr><tr><td rowspan="1" colspan="1">Sulph-200</td><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/><td rowspan="1" colspan="1"/></tr></tbody></table><table-wrap-foot><fn id="TF6"><p>*<italic>P</italic> &#x0003c; 0.05, **<italic>P</italic> &#x0003c; 0.01, ***<italic>P</italic> &#x0003c; 0.001, <italic>n</italic> = non-significant.</p></fn><fn><p>Statistical analyses were done between series p-DAB + PB + Alcohol versus p-DAB + PB + Nat Sulph-200.</p><p>p-DAB, p-dimethylaminoazobenzene; PB, phenobarbital; Nat Sulph-200, Natrum Sulphuricum-200; SE, standard error.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec><title>Results of Statistical Analysis</title><p>The significance of differences between data of the different series was determined by Student's <italic>t</italic>-test and the results of two-way ANOVA (Mini Tab 13.01) are summarized in <xref ref-type="table" rid="T2 T3 T4 T5 T6 T7">Tables 2&#x02013;7</xref> and <xref ref-type="table" rid="T8 T9">Table 8&#x02013;9</xref>.<table-wrap id="T8" position="float"><label>Table 8.</label><caption><p>Showing two-way ANOVA analyses for different cytogenetical parameters</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Two way ANOVA<hr/></th><th colspan="3" rowspan="1">Mitotic index<hr/></th><th colspan="2" rowspan="1">Chromosome Aberration<hr/></th><th colspan="2" rowspan="1">Micro nucleated Erythrocytes<hr/></th><th colspan="2" rowspan="1">Sperm Head Anomaly<hr/></th></tr><tr><th rowspan="1" colspan="1">Source of Variation</th><th rowspan="1" colspan="1">df</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Dues to Series</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">23.26</td><td rowspan="1" colspan="1">11.23<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">289.13</td><td rowspan="1" colspan="1">39.45<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">0.8247</td><td rowspan="1" colspan="1">95.82<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">5.26</td><td rowspan="1" colspan="1">15.02<xref ref-type="table-fn" rid="TF7">*</xref></td></tr><tr><td rowspan="1" colspan="1">Due to Days</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">11.67</td><td rowspan="1" colspan="1">5.64<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">45.85</td><td rowspan="1" colspan="1">6.26<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">0.03821</td><td rowspan="1" colspan="1">4.44<xref ref-type="table-fn" rid="TF7">*</xref></td><td rowspan="1" colspan="1">1.46</td><td rowspan="1" colspan="1">4.18<xref ref-type="table-fn" rid="TF7">*</xref></td></tr></tbody></table><table-wrap-foot><fn id="TF7"><p>*<italic>P</italic> &#x0003c; 0.05</p></fn></table-wrap-foot></table-wrap><table-wrap id="T9" position="float"><label>Table 9.</label><caption><p>Showing two-way ANOVA analyses for different enzymatic parameters</p></caption><table frame="hsides" rules="groups"><thead align="left"><tr><th rowspan="1" colspan="1">Two way ANOVA<hr/></th><th colspan="3" rowspan="1">AST activity<hr/></th><th colspan="2" rowspan="1">ALT activity<hr/></th><th colspan="2" rowspan="1">AcP activity<hr/></th><th colspan="2" rowspan="1">AlkP activity<hr/></th><th colspan="2" rowspan="1">LPO activity<hr/></th><th colspan="2" rowspan="1">GSH content<hr/></th></tr><tr><th rowspan="1" colspan="1">Source of Variation</th><th rowspan="1" colspan="1">df</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th><th rowspan="1" colspan="1">MS</th><th rowspan="1" colspan="1">F</th></tr></thead><tbody align="left"><tr><td rowspan="1" colspan="1">Dues to Series</td><td rowspan="1" colspan="1">4</td><td rowspan="1" colspan="1">0.0016054</td><td rowspan="1" colspan="1">17.90<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">0.0002548</td><td rowspan="1" colspan="1">14.12</td><td rowspan="1" colspan="1">0.003271</td><td rowspan="1" colspan="1">13.39</td><td rowspan="1" colspan="1">0.002043</td><td rowspan="1" colspan="1">4.10</td><td rowspan="1" colspan="1">0.02558<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">16.78</td><td rowspan="1" colspan="1">0.0000218</td><td rowspan="1" colspan="1">33.03</td></tr><tr><td rowspan="1" colspan="1">Due to Days</td><td rowspan="1" colspan="1">5</td><td rowspan="1" colspan="1">0.0009453</td><td rowspan="1" colspan="1">10.54<xref ref-type="table-fn" rid="TF8">*</xref></td><td rowspan="1" colspan="1">0.0000997</td><td rowspan="1" colspan="1">5.52</td><td rowspan="1" colspan="1">0.006541</td><td rowspan="1" colspan="1">26.79</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">6.06</td><td rowspan="1" colspan="1">0.03844</td><td rowspan="1" colspan="1">25.22</td><td rowspan="1" colspan="1">0.00</td><td rowspan="1" colspan="1">7.52</td></tr></tbody></table><table-wrap-foot><fn id="TF8"><p>*<italic>P</italic> &#x0003c; 0.05</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, several widely accepted toxicity markers have been used, all of which are known to have significant role during the carcinogenesis process (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B35 B36 B37 B38 B39 B40 B41 B42 B43 B44">35&#x02013;44</xref>). In brief, the significant reduction of biomarkers like AST, ALT, AcP, AlkP and LPO and increase of GSH in the drug fed series speak for the reduction of hepato-toxicity and injury (<xref ref-type="bibr" rid="B14">14</xref>,<xref ref-type="bibr" rid="B35">35</xref>). Positive modulations of several other parameters, such as, blood glucose, cholesterol, testosterone and estradiol were also noted (data not shown). Similarly, there were evidences from electron microscopic studies (both scanning, <xref ref-type="fig" rid="F3">Fig. 3</xref>; and transmission, <xref ref-type="fig" rid="F4">Fig. 4</xref>) on liver that the homeopathic remedy played a positive role in protecting ultra-structural integrities (data not shown). Incidentally, reactive oxygen species (ROS) are produced by metabolism of various endogenous and exogenous compounds and are associated in the pathogenesis of different liver diseases, such as cirrhosis and hepatocellular cancer (<xref ref-type="bibr" rid="B41 B42 B43 B44">41&#x02013;44</xref>). In cirrhosis and hepatocellular carcinoma, the antioxidant system is damaged severely and the GSH level falls down, the MDA level rises and GSH-dependent enzyme activities are enhanced in cirrhotic and cancer tissues (<xref ref-type="bibr" rid="B43">43</xref>). Incidentally, positive effects of homeopathic preparations on human prostate cancer growth have recently been studied by Maclaughlin <italic>et al.</italic> (<xref ref-type="bibr" rid="B45">45</xref>) and Jonas <italic>et al.</italic>, (<xref ref-type="bibr" rid="B46">46</xref>) while crude extracts of some plants have also been shown to have anti-cancerous activities against prostate cancer cell line in human (<xref ref-type="bibr" rid="B47">47</xref>) and in skin carcinogenesis (<xref ref-type="bibr" rid="B48">48</xref>) and leukemia and aging (<xref ref-type="bibr" rid="B49">49</xref>) of mice.<fig id="F3" position="float"><label>Figure 3.</label><caption><p>Section of liver under SEM: showing features of normal (3a-3b), p-DAB + PB + Alcohol fed (3c-3d) and p-DAB + PB + Nat Sulph-200 fed mice (3c-3f).</p></caption><graphic xlink:href="nem067f3"/></fig><fig id="F4" position="float"><label>Figure 4.</label><caption><p>Liver section under TEM: showing features of normal (4a-4b). p-DAB + PB + Alcohol fed (4c-4d) and p-DAB + PB + Nat sulph-200 fed mice (4c-4d).</p></caption><graphic xlink:href="nem067f4"/></fig></p><p>In recent years, cell death in brain cancer has been observed by some workers (<xref ref-type="bibr" rid="B50">50</xref>) by administering a homeopathic drug, Ruta 6, both on <italic>in vivo</italic> and <italic>in vitro</italic> systems. But how the micro doses of the highly diluted homeopathic remedy could bring about such positive changes in diverse parameters of study is not yet properly understood. The ability of the homeopathic remedy in bringing down cytogenetical damage along with the positive biochemical changes can be considered as proofs of their ability towards restoring normalcy in the functioning of body's important metabolic enzymes and mechanism of repair and retrieval for genome, presumably by activating/deactivating the relevant genes responsible for regulation of their respective activities (<xref ref-type="bibr" rid="B31">51</xref>,<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>).</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>Finally, compared with Nat Sulph-30, Nat Sulph-200 appeared to show a little better efficacy in reducing the incidence of tumors in liver, and most other common parameters tested with both potencies, particularly at some longer intervals of fixation. Therefore, other researchers are encouraged to replicate the study in mice and/or other mammalian models and see if potentized remedies of Natrum Sulphuricum can be recommended as a potential supportive medicine for use in human cancer therapy as well.</p></sec></body><back><ack><title>Acknowledgements</title><p>This work was financially supported by an EMR grant of AYUSH, Ministry of Health and Family Welfare, New Delhi to ARKB. The authors sincerely thank Dr. T.C. Nag, Associate Professor, Department of Anatomy, All India Institute of Medical Sciences, New Delhi, for his kind help in conducting the scanning and transmission electron microscopic studies. The authors express their sincere thanks to Dr. Philippe Belon, Director, Boiron Lab, Lyon, France, for kindly donating the Alc-200 for this work.</p></ack><ref-list><title>References</title><ref id="B1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ernst</surname><given-names>E</given-names></name></person-group><article-title>The current position of complementary/alternative medicine in cancer</article-title><source>Eur J Cancer</source><year>2003</year><volume>39</volume><fpage>2273</fpage><lpage>77</lpage><pub-id pub-id-type="pmid">14556917</pub-id></citation></ref><ref id="B2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Earnst</surname><given-names>E</given-names></name></person-group><article-title>Complementary or alternative therapies for osteoarthritis</article-title><source>Nat Clin Pract Rheumatol</source><year>2006</year><volume>2</volume><fpage>74</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">16932660</pub-id></citation></ref><ref id="B3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ricotti</surname><given-names>V</given-names></name><name><surname>Delanty</surname><given-names>N</given-names></name></person-group><article-title>Use of complementary and alternative medicine in epilepsy</article-title><source>Curr Neurol Neurosci Rep</source><year>2006</year><volume>6</volume><fpage>347</fpage><lpage>53</lpage><pub-id pub-id-type="pmid">16822357</pub-id></citation></ref><ref id="B4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Simpson</surname><given-names>CA</given-names></name></person-group><article-title>Complementary medicine in chronic pain treatment</article-title><source>Phys Med Rehabil Clin N Am</source><year>2006</year><volume>17</volume><fpage>451</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16616277</pub-id></citation></ref><ref id="B5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>MA</given-names></name><name><surname>Straus</surname><given-names>SE</given-names></name></person-group><article-title>Complementary and alternative medicine: Opportunities and Challenges for cancer management and research</article-title><source>Seminars in Oncology</source><year>2002</year><volume>29</volume><fpage>531</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">12516036</pub-id></citation></ref><ref id="B6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chrystal</surname><given-names>K</given-names></name><name><surname>Allan</surname><given-names>S</given-names></name><name><surname>Forgeson</surname><given-names>G</given-names></name><name><surname>Issacs</surname><given-names>R</given-names></name></person-group><article-title>The use of complementary and alternative medicine by cancer patients in New Zealand and regional cancer treatment center</article-title><source>New Zealand Med J</source><year>2003</year><volume>116</volume><fpage>1</fpage><lpage>8</lpage></citation></ref><ref id="B7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molassiotis</surname><given-names>A</given-names></name><name><surname>Panteli</surname><given-names>V</given-names></name><name><surname>Patiraki</surname><given-names>E</given-names></name><name><surname>Ozden</surname><given-names>G</given-names></name><name><surname>Platin</surname><given-names>N</given-names></name><name><surname>Madsen</surname><given-names>E</given-names></name><etal/></person-group><article-title>Complementary and alternative medicine use in lung cancer patients in eight European countries</article-title><source>Complement Ther Clin Pract</source><year>2006</year><volume>12</volume><fpage>34</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">16401528</pub-id></citation></ref><ref id="B8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Molassiotis</surname><given-names>A</given-names></name><name><surname>Margulies</surname><given-names>A</given-names></name><name><surname>Fernandez-Ortega</surname><given-names>P</given-names></name><name><surname>Pud</surname><given-names>D</given-names></name><name><surname>Panteli</surname><given-names>V</given-names></name><name><surname>Bruyns</surname><given-names>I</given-names></name><etal/></person-group><article-title>Complementary and alternative medicine use in patients with hematological malignancies in Europe</article-title><source>Complement Ther Clin Pract</source><year>2005</year><volume>11</volume><fpage>105</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">15955292</pub-id></citation></ref><ref id="B9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bensoussan</surname><given-names>M</given-names></name><name><surname>Jovenin</surname><given-names>N</given-names></name><name><surname>Garcia</surname><given-names>B</given-names></name><name><surname>Vandromme</surname><given-names>L</given-names></name><name><surname>Jolly</surname><given-names>D</given-names></name><name><surname>Bouche</surname><given-names>O</given-names></name><etal/></person-group><article-title>Complementary and alternative medicine use by patients with inflammatory bowel disease: results from a postal survey</article-title><source>Gastroenterol Clin Biol</source><year>2006</year><volume>30</volume><fpage>14</fpage><lpage>23</lpage><pub-id pub-id-type="pmid">16514377</pub-id></citation></ref><ref id="B10"><label>10</label><citation citation-type="web"><person-group person-group-type="author"><name><surname>Joos</surname><given-names>S</given-names></name><name><surname>Rosemann</surname><given-names>T</given-names></name><name><surname>Szecsenyi</surname><given-names>J</given-names></name><name><surname>Hahn</surname><given-names>EG</given-names></name><name><surname>Willich</surname><given-names>SN</given-names></name><name><surname>Brinkhaus</surname><given-names>B</given-names></name></person-group><article-title>Use of complementary and alternative medicine in Germany - a survey of patients with inflammatory bowel disease</article-title><source>BMC Complement Altern Med</source><year>2006</year><volume>6</volume><issue>19</issue><comment>doi: 10.1186/1472-6882-6-19. <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1472-6882/6/19">http://www.biomedcentral.com/1472-6882/6/19</ext-link></comment></citation></ref><ref id="B11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Effect of a homeopathic drug, Chelidonium, in amelioration of p-Dab induced hepatocarcinogenesis in mice</article-title><source>BMC Complement Altern Med</source><year>2002</year><volume>2</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="pmid">11825344</pub-id></citation></ref><ref id="B12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Evaluation of protective potentials of a potentized homeopathic drug, <italic>Chelidonium majus</italic>, during azo dye induced hepatocarcinogenesis in mice</article-title><source>Indian J Exp Biol</source><year>2004</year><volume>42</volume><fpage>698</fpage><lpage>714</lpage><pub-id pub-id-type="pmid">15339035</pub-id></citation></ref><ref id="B13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>N</given-names></name><name><surname>Das</surname><given-names>JK</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Efficacy of a potentized homeopathic drug, Carcinosin-200, fed alone and in combination with another drug, Chelidonium-200, in amelioration of p-Dab induced hepatocarcinogenesis in mice</article-title><source>J Altern Complement Med</source><year>2005</year><volume>11</volume><fpage>839</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">16296917</pub-id></citation></ref><ref id="B14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Das</surname><given-names>JK</given-names></name><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Protective potentials of a potentized homeopathic drug, Lycopodium-30, in ameliorating azo dye induced hepatocarcinogenesis in mice</article-title><source>Mol Cell Biochem</source><year>2006</year><volume>258</volume><fpage>121</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">16538399</pub-id></citation></ref><ref id="B15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Daust</surname><given-names>R</given-names></name><name><surname>Molnar</surname><given-names>F</given-names></name></person-group><article-title>Cellular populations and mitotic activity in rat liver parenchyma during azo dye carcinogenesis</article-title><source>Cancer Res</source><year>1964</year><volume>24</volume><fpage>1898</fpage><lpage>1909</lpage><pub-id pub-id-type="pmid">14247501</pub-id></citation></ref><ref id="B16"><label>16</label><citation citation-type="journal"><collab>IARC (International Agency for Research on Cancer)</collab><article-title>On the evaluation of carcinogenic risk of chemicals to man</article-title><source>Group-2B</source><year>1987</year><volume>7</volume><fpage>449</fpage></citation></ref><ref id="B17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohnishi</surname><given-names>S</given-names></name><name><surname>Murata</surname><given-names>M</given-names></name><name><surname>Degawa</surname><given-names>M</given-names></name><name><surname>Kawanishi</surname><given-names>S</given-names></name></person-group><article-title>Oxidative DNA damage induced by an N-hydroxy metabolite of carcinogenic 4-dimethylaminoazobenzene</article-title><source>Jpn J Cancer Res</source><year>2001</year><volume>92</volume><fpage>23</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11173540</pub-id></citation></ref><ref id="B18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Merkulova</surname><given-names>TI</given-names></name><name><surname>Kropachev</surname><given-names>KY</given-names></name><name><surname>Timofeeva</surname><given-names>OA</given-names></name><name><surname>Vasiliev</surname><given-names>GV</given-names></name><name><surname>Levashova</surname><given-names>ZB</given-names></name><name><surname>Ilnitskaya</surname><given-names>SI</given-names></name><etal/></person-group><article-title>Species-specific effects of the hepatocarcinogens 3&#x02032;- methyl-4-dimehylaminoazobenzene and ortho-aminoazotoluene in mouse and rat liver</article-title><source>Mol Carcinog</source><year>2005</year><volume>44</volume><fpage>223</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">16267830</pub-id></citation></ref><ref id="B19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Cytotoxic and genotoxic effects of the azo-dye p-dimethylaminoazobenzene in mice: A time-course study</article-title><source>Mutat Res</source><year>2005</year><volume>587</volume><fpage>1</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16202644</pub-id></citation></ref><ref id="B20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siemiatycki</surname><given-names>J</given-names></name><name><surname>Richardson</surname><given-names>L</given-names></name><name><surname>Straif</surname><given-names>K</given-names></name><name><surname>Latreille</surname><given-names>B</given-names></name><name><surname>Lakhani</surname><given-names>R</given-names></name><name><surname>Campbell</surname><given-names>S</given-names></name><etal/></person-group><article-title>Listing occupational carcinogens: research Review</article-title><source>Environ Health Perspect</source><year>2004</year><volume>112</volume><fpage>1447</fpage><lpage>59</lpage><pub-id pub-id-type="pmid">15531427</pub-id></citation></ref><ref id="B21"><label>21</label><citation citation-type="web"><collab>NTP</collab><article-title>Report on Carcinogens. (11th edn). Research Triangle Park, NC</article-title><source>National Toxicology Program</source><year>2005</year><comment>(Retrieved from <ext-link ext-link-type="uri" xlink:href="http://ntp.niehs.nih.gov/index.cfm?Objectid=32BA9724-F1F6-975E-7FCE50709CB4C932">http://ntp.niehs.nih.gov/index.cfm?Objectid=32BA9724-F1F6-975E-7FCE50709CB4C932</ext-link>)</comment></citation></ref><ref id="B22"><label>22</label><citation citation-type="journal"><collab>IARC (International Agency for Research on Cancer)</collab><article-title>Phenobarbital and Sodium salt</article-title><source>IARC monograph</source><year>2001</year><volume>79</volume><fpage>161</fpage></citation></ref><ref id="B23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>White</surname><given-names>SJ</given-names></name><name><surname>McLean</surname><given-names>AEM</given-names></name><name><surname>Howland</surname><given-names>C</given-names></name></person-group><article-title>Anticonvulsant drugs and cancer, A cohort study in patients with severe epilepsy</article-title><source>Lancet</source><year>1979</year><volume>ii</volume><fpage>458</fpage><lpage>61</lpage><pub-id pub-id-type="pmid">89512</pub-id></citation></ref><ref id="B24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>GH</given-names></name></person-group><article-title>Paradoxical effects of phenobarbital on mouse carcinogenesis</article-title><source>Toxicol Pathol</source><year>2000</year><volume>28</volume><fpage>215</fpage><lpage>25</lpage><pub-id pub-id-type="pmid">10805139</pub-id></citation></ref><ref id="B25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kinoshita</surname><given-names>A</given-names></name><name><surname>Wanibuchi</surname><given-names>H</given-names></name><name><surname>Morimura</surname><given-names>K</given-names></name><name><surname>Wei</surname><given-names>M</given-names></name><name><surname>Shen</surname><given-names>J</given-names></name><name><surname>Imaoka</surname><given-names>S</given-names></name><etal/></person-group><article-title>Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression</article-title><source>Carcinogenesis</source><year>2003</year><volume>24</volume><fpage>1389</fpage><lpage>99</lpage><pub-id pub-id-type="pmid">12807726</pub-id></citation></ref><ref id="B26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Biswas</surname><given-names>SJ</given-names></name><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Assessment of the genotoxic and cytotoxic potential of an antiepileptic drug Phenobarbital, in mice: A time course study</article-title><source>Mutat Res</source><year>2004</year><volume>563</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="pmid">15324744</pub-id></citation></ref><ref id="B27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Palekar</surname><given-names>SD</given-names></name><name><surname>Sirsat</surname><given-names>SM</given-names></name></person-group><article-title>Studies on the hepatocyte in azo dye carcinogenesis</article-title><source>Indian J Exp Boil</source><year>1966</year><volume>4</volume><fpage>73</fpage><lpage>8</lpage></citation></ref><ref id="B28"><label>28</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Boericke</surname><given-names>W</given-names></name></person-group><article-title/><source>Pocket Manual of Homeopathic Materia Medica</source><year>1976</year><edition>Indian</edition><publisher-loc>Calcutta, India</publisher-loc><publisher-name>Sett Dey and Co.</publisher-name></citation></ref><ref id="B29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>T</given-names></name><name><surname>Sugano</surname><given-names>H</given-names></name></person-group><article-title>Enhancing effect of phenobarbital on the development of enzyme-altered islands and hepatocellular carcinomas initiated by 3&#x02032;-methyl-4-(dimethylamino) azobenzene or diethylnitrosamine</article-title><source>Gann</source><year>1978</year><volume>69</volume><fpage>679</fpage><lpage>87</lpage><pub-id pub-id-type="pmid">153254</pub-id></citation></ref><ref id="B30"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitagawa</surname><given-names>T</given-names></name><name><surname>Sugano</surname><given-names>H</given-names></name></person-group><article-title>Enhancement of azo-dye hepatocarcinogenesis with dietary phenobarbital in rats</article-title><source>Gann</source><year>1977</year><volume>68</volume><fpage>255</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">142681</pub-id></citation></ref><ref id="B31"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Towards understanding molecular mechanisms of action of homeopathic drugs: An overview</article-title><source>Mol Cell Biochem</source><year>2003</year><volume>253</volume><fpage>339</fpage><lpage>45</lpage><pub-id pub-id-type="pmid">14619985</pub-id></citation></ref><ref id="B32"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Laboratory research in homeopathy: pro</article-title><source>Integr Cancer Ther</source><year>2006</year><volume>5</volume><fpage>320</fpage><lpage>32</lpage><pub-id pub-id-type="pmid">17101761</pub-id></citation></ref><ref id="B33"><label>33</label><citation citation-type="book"><source>Homeopathic Pharmacopoeia of India</source><year>1971</year><volume>1</volume><publisher-name>Ministry of Health. Government of India Press</publisher-name><fpage>165</fpage><comment>Coimbatore-641019: Controller of Publications</comment></citation></ref><ref id="B34"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Bhattacharjee</surname><given-names>N</given-names></name><name><surname>Das</surname><given-names>JK</given-names></name><name><surname>Chaki Chowdhury</surname><given-names>S</given-names></name><name><surname>Roy Karmakar</surname><given-names>S</given-names></name><name><surname>Banerjee</surname><given-names>P</given-names></name><etal/></person-group><article-title>Supportive evidences for anti-cancerous potential of an alternative medicine in hepatocarcinogenesis of mice</article-title><source>Res Com Med</source><year>2007</year><volume>14</volume><fpage>132</fpage><comment>June issue, (DOI:10.1159/000102007)</comment></citation></ref><ref id="B35"><label>35</label><citation citation-type="book"><person-group person-group-type="author"><name><surname>Plaa</surname><given-names>GL</given-names></name><name><surname>Amdun</surname><given-names>AM</given-names></name><name><surname>Doull</surname><given-names>J</given-names></name><name><surname>Klasser</surname><given-names>CD</given-names></name></person-group><article-title/><source>Toxic responses of the liver</source><year>1991</year><edition>4th</edition><publisher-name>London UK: Pergamon Press</publisher-name></citation></ref><ref id="B36"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Chan</surname><given-names>KY</given-names></name><name><surname>Wong</surname><given-names>N</given-names></name><name><surname>Lai</surname><given-names>PB</given-names></name><name><surname>Squire</surname><given-names>JA</given-names></name><name><surname>Macgregor</surname><given-names>PF</given-names></name><name><surname>Behesthi</surname><given-names>B</given-names></name><etal/></person-group><article-title>Transcriptional profiling on chromosome 19p indicated frequent down regulation of ACP5 expression in hepatocellular carcinoma</article-title><source>Int J cance</source><year>2005</year><volume>114</volume><fpage>902</fpage><lpage>8</lpage></citation></ref><ref id="B37"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Reichling</surname><given-names>JJ</given-names></name><name><surname>Kaplan</surname><given-names>MM</given-names></name></person-group><article-title>Clinical use of serum enzymes in liver diseases</article-title><source>Dig Dis Sci</source><year>1988</year><volume>33</volume><fpage>1601</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">2904353</pub-id></citation></ref><ref id="B38"><label>38</label><citation citation-type="web"><person-group person-group-type="author"><name><surname>Wiwanitkit</surname><given-names>V</given-names></name></person-group><article-title>High serum alkaline phosphatase levels, a study in 181 Thai adult hospitalized patients</article-title><source>BMC Family Practice</source><year>2001</year><volume>2</volume><fpage>2</fpage><comment>(retrieved from <ext-link ext-link-type="uri" xlink:href="http://www.biomedcentral.com/1471-2296/2/2">http://www.biomedcentral.com/1471-2296/2/2</ext-link>)</comment><pub-id pub-id-type="pmid">11545676</pub-id></citation></ref><ref id="B39"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marnett</surname><given-names>LJ</given-names></name></person-group><article-title>Lipid peroxidation-DNA damage by malondialdehyde</article-title><source>Mutat Res</source><year>1999</year><volume>424</volume><fpage>83</fpage><lpage>95</lpage><pub-id pub-id-type="pmid">10064852</pub-id></citation></ref><ref id="B40"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mishra</surname><given-names>S</given-names></name><name><surname>Sharma</surname><given-names>DC</given-names></name><name><surname>Sharma</surname><given-names>P</given-names></name></person-group><article-title>Studies of biochemical parameters in breast cancer with and without metastasis</article-title><source>Indian J Clin Biochem</source><year>2004</year><volume>19</volume><fpage>71</fpage><lpage>5</lpage></citation></ref><ref id="B41"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Dreher</surname><given-names>D</given-names></name><name><surname>Junod</surname><given-names>AF</given-names></name></person-group><article-title>Role of oxygen free radicals in cancer development</article-title><source>Eur J Cancer</source><year>1996</year><volume>32A</volume><fpage>30</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">8695238</pub-id></citation></ref><ref id="B42"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jungst</surname><given-names>C</given-names></name><name><surname>Cheng</surname><given-names>B</given-names></name><name><surname>Gehrke</surname><given-names>R</given-names></name><name><surname>Schmitz</surname><given-names>V</given-names></name><name><surname>Nischalke</surname><given-names>HD</given-names></name><name><surname>Ramakers</surname><given-names>J</given-names></name><etal/></person-group><article-title>Oxidative damage is increased in human liver tissue adjacent to hepatocellular carcinoma</article-title><source>Hepatology</source><year>2004</year><volume>39</volume><fpage>1663</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">15185308</pub-id></citation></ref><ref id="B43"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balasubramanian</surname><given-names>S</given-names></name><name><surname>Kowdley</surname><given-names>KV</given-names></name></person-group><article-title>Effect of alcohol on viral hepatitis and other forms of liver dysfunction</article-title><source>Clin Liver Dis</source><year>2005</year><volume>9</volume><fpage>83</fpage><lpage>101</lpage><pub-id pub-id-type="pmid">15763231</pub-id></citation></ref><ref id="B44"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Czeczot</surname><given-names>H</given-names></name><name><surname>Scibior</surname><given-names>D</given-names></name><name><surname>Skrzycki</surname><given-names>M</given-names></name><name><surname>Podsiad</surname><given-names>M</given-names></name></person-group><article-title>Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma</article-title><source>Acta Biochem Pol</source><year>2006</year><volume>53</volume><fpage>237</fpage><lpage>42</lpage></citation></ref><ref id="B45"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Maclaughlin</surname><given-names>BW</given-names></name><name><surname>Gutsmuths</surname><given-names>B</given-names></name><name><surname>Pretner</surname><given-names>E</given-names></name><name><surname>Jonas</surname><given-names>WB</given-names></name><name><surname>Ives</surname><given-names>J</given-names></name><name><surname>Kulawardane</surname><given-names>DV</given-names></name><etal/></person-group><article-title>Effects of homeopathic preparations on human prostate cancer growth in cellular and animal models</article-title><source>Integr Cancer Ther</source><year>2006</year><volume>5</volume><fpage>362</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">17101766</pub-id></citation></ref><ref id="B46"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonas</surname><given-names>WB</given-names></name><name><surname>Gaddipati</surname><given-names>JP</given-names></name><name><surname>Rajeshkumar</surname><given-names>NV</given-names></name><name><surname>Sharma</surname><given-names>A</given-names></name><etal/></person-group><article-title>Can homeopathic treatment slow prostate cancer growth?</article-title><source>Integr Cancer Ther</source><year>2006</year><volume>5</volume><fpage>343</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">17101763</pub-id></citation></ref><ref id="B47"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Adams</surname><given-names>LS</given-names></name><name><surname>Seeram</surname><given-names>NP</given-names></name><name><surname>Hardy</surname><given-names>ML</given-names></name><name><surname>Carpenter</surname><given-names>C</given-names></name><name><surname>Heber</surname><given-names>D</given-names></name></person-group><article-title>Analysis of the Interactions of Botanical Extract Combinations Against the Viability of Prostate Cancer Cell Lines</article-title><source>eCAM</source><year>2006</year><volume>3</volume><fpage>117</fpage><lpage>24</lpage><pub-id pub-id-type="pmid">16550232</pub-id></citation></ref><ref id="B48"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Padmavathi</surname><given-names>B</given-names></name><name><surname>Rath</surname><given-names>PC</given-names></name><name><surname>Rao</surname><given-names>AR</given-names></name><name><surname>Singh</surname><given-names>RP</given-names></name></person-group><article-title>Roots of <italic>Withania somnifera</italic> Inhibit Forestomach and Skin Carcinogenesis in Mice</article-title><source>Evid Based Compliment Alernat Med</source><year>2005</year><volume>2</volume><fpage>99</fpage><lpage>105</lpage></citation></ref><ref id="B49"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>SC</given-names></name></person-group><article-title><italic>Echinacea</italic>: a Miracle Herb against Aging and Cancer? Evidence <italic>In vivo</italic> in Mice</article-title><source>Evid Based Compliment Alternat Med</source><year>2005</year><volume>2</volume><fpage>309</fpage><lpage>14</lpage></citation></ref><ref id="B50"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Pathak</surname><given-names>S</given-names></name><name><surname>Multani</surname><given-names>AS</given-names></name><name><surname>Banerjee</surname><given-names>P</given-names></name></person-group><article-title>Ruta 6 selectively induced cell death in brain cancer cells but proliferation in normal peripheral blood lymphocytes: A novel treatment for human brain cancer</article-title><source>Int J Oncol</source><year>2003</year><volume>23</volume><fpage>975</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">12963976</pub-id></citation></ref><ref id="B51"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Khuda-Bukhsh</surname><given-names>AR</given-names></name></person-group><article-title>Potentized homeopathic drugs act through regulation of gene expression: a hypothesis to explain their mechanism and pathways of action <italic>in vivo</italic></article-title><source>Com Ther Med</source><year>1997</year><volume>5</volume><fpage>13</fpage><lpage>46</lpage></citation></ref></ref-list></back></article>